National Cancer Institute NCI Cancer Bulletin: A Trusted Source for Cancer Research News
May 18, 2010 • Volume 7 / Number 10

BREAKING NEWS

President to Appoint Dr. Harold Varmus to Lead NCI

Yesterday, President Barack Obama announced his intent to appoint Dr. Harold Varmus to serve as director of the National Cancer Institute.

In an e-mail to the NCI staff yesterday, Director of NIH Dr. Francis Collins said that Dr. Varmus "brings unmatched expertise at all levels—not only in cutting edge scientific research, but also as a leader in the development of strategies for improving patient care, in scientific education and training, and in the design of novel public-private partnerships."

For additional coverage of this important development, be sure to read upcoming issues of the NCI Cancer Bulletin.

COMMENTARY

Director's Update: For Clinical Trials, a Time of Challenge, Change, and Opportunity

Last month, the prestigious Institute of Medicine released a report on clinical trials for cancer. That report, A National Cancer Clinical Trials System for the 21st Century, discusses weaknesses of the Cooperative Group clinical trials system supported by NCI, and it includes four recommendations suggesting, among other items, that NCI improve the speed and efficiency of clinical trials, incorporate more innovative science into trial design, improve the prioritization of trials so that more trials are run to completion, and find incentives to encourage patients and physicians to participate. Read more > >

Watch the Inside NCI video

Inside NCI: A Conversation with Dr. Jeff Abrams about Cancer Clinical Trials

The associate director of NCI's Cancer Therapy Evaluation Program discusses some of the challenges and opportunities in coordinating the largest publicly funded oncology clinical trials organization in the world. Read more > >

NEWS

Cancer Trials Accrual Tool Focuses on Solutions

NCI researchers last month unveiled a new online tool for clinicians and professionals who recruit people to join cancer clinical trials. The tool, called AccrualNet, is both a repository of information and a forum for professionals to exchange ideas about the challenges associated with developing and managing these important studies. Read more > >

  

HIGHLIGHTS
SUPPLEMENT TO THE SPECIAL ISSUE

UPDATES
SUPPLEMENT TO THE SPECIAL ISSUE

  • Legislative Update

    • Cures Acceleration Network Featured at Senate Appropriations Subcommittee Hearing
  • Cancer.gov Update

    • Recovery Act Web Site Highlights NCI Clinical Proteomic Technologies for Cancer Initiative
  • Notes

    • PLCO EEMS Seeks Applicants
    • Enter the Celebrating Smokefree Voices Video Contest
    • Meet NCI Experts at ASCO
    • Abstracts Accepted for the Molecular Markers in Cancer Meeting
    • President's Cancer Panel Issues Report on Environmental Cancer Risks
    • Updated NCI Spanish-language Booklet on Breast Cancer

Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.

The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.

NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.

Next Section >